Copyright
©The Author(s) 2016.
World J Gastroenterol. Oct 7, 2016; 22(37): 8414-8434
Published online Oct 7, 2016. doi: 10.3748/wjg.v22.i37.8414
Published online Oct 7, 2016. doi: 10.3748/wjg.v22.i37.8414
Ref. | Year | TRG scale used (original disease application) | Are the scales reported accurately? | Good response definition | Total (n) | Good responders (n) | Average F/up in months | LR (%) 5 yr | DR (%) 5 yr | DFS (%) | OS (%) |
Gambacorta et al[21] | 2004 | Mandard (oesophagus) | Yes | TRG 1 and 2 | 54 | 24 | 25 | ||||
Pucciarelli et al[28] | 2004 | Mandard (oesophagus) | Yes | TRG 1 and 2 and 3 | 104 | 52 | 42 | DNE | DNE | ||
Horisberger et al[24] | 2008 | Japanese Society for Cancer of the Colon and Rectum (rectal) | Yes | TRG 2 and 3 | 59 | 33 | |||||
Suárez et al[31] | 2008 | Mandard (oesophagus) | Yes | TRG 1 and 2 | 119 | 36 | 33 | 0 | 0 | DNE | |
Bujko et al[18] | 2010 | Glynne Jones/Bujko (rectal) | Yes | TRG 1 | 131 | 40 | 48 | 9 | 34 | Yr. 4: 67 | |
Avallone et al[13] | 2011 | Mandard (oesophagus) | Yes | TRG 2 and 3 | 63 | 20 | 60 | Yr. 5: Prob free of recurrence > 90% | |||
Shin et al[30] | 2011 | Mandard (oesophagus) | Yes | TRG 1 and 2 and 3 | 102 | 52 | 40.3 | Yr. 3: 74.1 | |||
Huebner et al[25] | 2012 | Dworak (rectal) | Yes | TRG 2 and 3 and 4 | 237 | 176 | |||||
Lim et al[26] | 2012 | Dworak (rectal) | Yes | TRG 3 and 4 | 581 | 224 | 61 | 1.3 | 11.6 | Yr. 5: 86.7 | Yr. 5: 88.2 |
Roy et al[29] | 2012 | Dworak (rectal) | Yes | TRG 2 and 3 and 4 | 75 | 33 | Yr. 2: 91.7 | Yr. 2: 89.2 | |||
Roy et al[29] | 2012 | Mandard (oesophagus) | Yes | TRG 1 and 2 and 3 | 75 | 51 | Yr. 2: 86.1 | Yr. 2: 92.2 | |||
Vallböhmer et al[32] | 2012 | Japanese Society for Cancer of the Colon and Rectum (rectal) | Yes | TRG 3 | 85 | 23 | DNE | ||||
Vallböhmer et al[32] | 2012 | Junker Miller (lung) | Yes | TRG 2aand2b | 85 | 65 | DNE | ||||
Vallböhmer et al[32] | 2012 | Cologne (oesophageal) | Yes | TRG 3 and 4 | 85 | 26 | DNE | ||||
Winkler et al[33] | 2012 | Dworak (rectal) | No | TRG 3 | 33 | 6 | |||||
Elezkurtaj et al[20] | 2013 | Dworak (rectal) | Yes | TRG 3 and 4 | 102 | 34 | |||||
Fokas et al[14] | 2014 | Dworak (rectal) | Yes | TRG 2 and 3 | 386 | 256 | 132 | Yr. 10: 8.0 | Yr. 10: 29.3 | Yr. 10: 73.6% | |
Santos et al[16] | 2014 | Dworak (rectal) | Yes | TRG 3 and 4 | 144 | 54 | 56 | 1.8 | 11.1 | Yr. 5: 78.4 | Yr. 5: 77.4 |
Santos et al[16] | 2014 | Mandard (oesophagus) | Yes | TRG 1 and 2 | 144 | 70 | 56 | 1.4 | 8.6 | Yr. 5: 81.7 | Yr. 5: 79.4 |
Hav et al[15] | 2015 | Dworak (rectal) | Yes | TRG 3 and 4 | 76 | 28 | 20 | No specific data but no correlation with DFS |
- Citation: Siddiqui MRS, Bhoday J, Battersby NJ, Chand M, West NP, Abulafi AM, Tekkis PP, Brown G. Defining response to radiotherapy in rectal cancer using magnetic resonance imaging and histopathological scales. World J Gastroenterol 2016; 22(37): 8414-8434
- URL: https://www.wjgnet.com/1007-9327/full/v22/i37/8414.htm
- DOI: https://dx.doi.org/10.3748/wjg.v22.i37.8414